(24)
(20)
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - AF2012 at 1/100 staining mouse testis tissue sections by IHC-P.](http://img.affbiotech.cn/images/201707/thumb_img/1183_thumb_P_1499914796141.jpg "AF2012 at 1/100 staining mouse testis tissue sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary antibody.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - AF2012 at 1/100 staining mouse lung tissue sections by IHC-P.](http://img.affbiotech.cn/images/201707/thumb_img/1183_thumb_P_1499914796519.jpg "AF2012 at 1/100 staining mouse lung tissue sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary antibody.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - AF2012 at 1/100 staining mouse intestinal tissue sections by IHC-P.](http://img.affbiotech.cn/images/201707/thumb_img/1183_thumb_P_1499914796678.jpg "AF2012 at 1/100 staining mouse intestinal tissue sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary antibody.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - AF2012 at 1/100 staining rat uterine tissue sections by IHC-P.](http://img.affbiotech.cn/images/201707/thumb_img/1183_thumb_P_1499914796823.jpg "AF2012 at 1/100 staining rat uterine tissue sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary antibody.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - AF2012 at 1/100 staining rat appendiceal tissue sections by IHC-P.](http://img.affbiotech.cn/images/201707/thumb_img/1183_thumb_P_1499914796555.jpg "AF2012 at 1/100 staining rat appendiceal tissue sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary antibody.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - AF2012 at 1/100 staining rat intestinal tissue sections by IHC-P.](http://img.affbiotech.cn/images/201707/thumb_img/1183_thumb_P_1499914796697.jpg "AF2012 at 1/100 staining rat intestinal tissue sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary antibody.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - AF2012 at 1/100 staining human appendiceal tissue sections by IHC-P.](http://img.affbiotech.cn/images/201707/thumb_img/1183_thumb_P_1499914796116.jpg "AF2012 at 1/100 staining human appendiceal tissue sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary antibody.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - AF2012 at 1/100 staining human seminoma tissue sections by IHC-P.](http://img.affbiotech.cn/images/201707/thumb_img/1183_thumb_P_1499914796516.jpg "AF2012 at 1/100 staining human seminoma tissue sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary antibody.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - AF2012 at 1/100 staining human muscle tumor tissue sections by IHC-P.](http://img.affbiotech.cn/images/201707/thumb_img/1183_thumb_P_1499914796158.jpg "AF2012 at 1/100 staining human muscle tumor tissue sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary antibody.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - AF2012 staining lovo cells by ICC/IF.](http://img.affbiotech.cn/images/201708/thumb_img/1183_thumb_P_1503278939353.jpg "AF2012 staining lovo cells by ICC/IF. Cells were fixed with PFA and permeabilized in 0.1% saponin prior to blocking in 10% serum for 45 minutes at 37°C. The primary antibody was diluted 1/400 and incubated with the sample for 1 hour at 37°C. A Alexa Fluor® 594 conjugated goat polyclonal to rabbit IgG (H+L), diluted 1/600 was used as secondary antibody.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - peptide-ELISA analysis of AF2012.](http://img.affbiotech.cn/images/pelisa/809/af2012-peptide-elisa.png "peptide-ELISA analysis of AF2012. showing specificity to antigen peptide. Peptides concentration: 1ug/ml.<br>
P-peptide: phospho-peptide. N-peptide: non-phospho-peptide.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - Figure 6.](http://img.affbiotech.cn/images/cited_image/202111/27770580_20180914230126.jpg "Figure 6. Effect of BCL2L10 on its downstream gene expression profiles of human cancer pathway in HepG2 cells. (A) By human cancer pathway PCR array, ectopic expression of BCL2L10 up- or down-regulated several genes related to tumor proliferation, apoptosis, metastasis and angiogenesis. (B) Western blot was performed to confirm the downstream gene expression regulated by BCL2L10 in HepG2 cells. GAPDH was used as an internal control. (C) Schematic diagram of the molecular events for BCL2L10 function as a tumor suppressor through regulating cell cycle, proliferation, apoptosis metastasis and angiogenesis effectors.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - Figure 5.](http://img.affbiotech.cn/images/cited_image/202110/cited_img_235.jpg "Figure 5. | GM-CSF increase the mRNA expression level of Nav1.7, Nav1.8, 822 Nav1.9 channel through Jak2-Stat3 signaling pathway. (A) Relative expression of 823 p-Jak1, p-Jak2, p-Jak3, p-stat3 and p-stat5 in DRG neurons after incubation with 824 GM-CSF for 25 mins. (n=3, unpaired t-test, *P < 0.05 as compared to control)")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - Figure 3.](http://img.affbiotech.cn/images/cited_image/202112/cite-wx-74-1640698918.jpg "Figure 3.| The gemcitabine-erlotinib (E+G) combination group inhibits the activity of the JAK-STAT pathway, as well as the expression of downstream HIF‑1α, cyclin D1 and p53. (E) Phosphorylation levels of JAK1 (Tyr1022), JAK2 (Tyr221), JAK3(Tyr981) and STAT3 (Tyr701) in BxPC-3 and PANC‑1 cells were analyzed by western blotting, respectively.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - Figure 5
A‐F, The expression of JAK1, p‐JAK1, JAK2, p‐JAK2, STAT1, and p‐STAT1 in macrophages within each group as determined by western blot analysis.](http://img.affbiotech.cn/images/cited_image/202207/cite-wx-65-1658977738.jpg "Figure 5
A‐F, The expression of JAK1, p‐JAK1, JAK2, p‐JAK2, STAT1, and p‐STAT1 in macrophages within each group as determined by western blot analysis. G‐I, Quantitative analysis of the bands measured by gray value. The experiment was carried out a minimum of three times, and values are expressed as the mean ± SD. *P < .05 and **P < .01 compared with MI. JAK, Janus kinase; STAT, signal transducer and activator of transcription [Color figure can be viewed at wileyonlinelibrary.com]")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - Figure 4: Relative mRNA and protein expression levels of JAK1, STAT6, and SOCS1.](http://img.affbiotech.cn/uploads/202402/230e7cd398554d391a461360d295fd68.png "Figure 4: Relative mRNA and protein expression levels of JAK1, STAT6, and SOCS1.")
![Phospho-JAK1 (Tyr1022)[Tyr1034] Antibody - Figure 5 .](http://img.affbiotech.cn/uploads/202508/e24e742bbe62ffb2b013bac035b91baf.png "Figure 5 . MR deficiency impairs the BCG-induced p-JAK1-p-STAT1-MHC-II pathway in macrophages (A) WT and Mr‒/‒ BMDMs were incubated with BCG for the indicated durations. The nuclear, cytoplasmic and total expression levels of pJAK1, JAK1, pSTAT1 and STAT1 in the cells were determined by immunoblotting analysis. (B) WT and Mr‒/‒ BMDMs were incubated with BCG for 1 h. After the removal of extracellular bacteria by washing, the cells were further cultured for 2 h, and nuclear STAT1 was measured by confocal microscopy (scale bar: 5 μm). WT and Mr‒/‒ BMDMs were treated with the STAT1 inhibitor fludarabine prior to incubation with BCG. The expression levels of the surface proteins MHC-I/II, CD80 and CD86 were analyzed by FCM. (C) Experimental scheme. (D) Pooled MFI data for MHC-I/II, CD80 and CD86 in BMDMs. (E) Representative FCM histogram. Data are presented as the mean±SD (n=3) and were evaluated by ANOVA followed by the Neuman-Keuls post hoc test (*P")
产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# AF2012, RRID:AB_2834437.
展开/折叠
JAK 1; JAK 1A; JAK 1B; JAK-1; JAK1; JAK1_HUMAN; JAK1A; JAK1B; Janus kinase 1 (a protein tyrosine kinase); Janus kinase 1; JTK3; Tyrosine protein kinase JAK 1; Tyrosine protein kinase JAK1; Tyrosine-protein kinase JAK1;
抗原和靶标
A synthesized peptide derived from human JAK1 around the phosphorylation site of Tyr1034.
研究领域
· Cellular Processes > Cell growth and death > Necroptosis. (View pathway)
· Cellular Processes > Cellular community - eukaryotes > Signaling pathways regulating pluripotency of stem cells. (View pathway)
· Environmental Information Processing > Signal transduction > PI3K-Akt signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Jak-STAT signaling pathway. (View pathway)
· Human Diseases > Drug resistance: Antineoplastic > EGFR tyrosine kinase inhibitor resistance.
· Human Diseases > Infectious diseases: Parasitic > Leishmaniasis.
· Human Diseases > Infectious diseases: Parasitic > Toxoplasmosis.
· Human Diseases > Infectious diseases: Bacterial > Tuberculosis.
· Human Diseases > Infectious diseases: Viral > Hepatitis C.
· Human Diseases > Infectious diseases: Viral > Hepatitis B.
· Human Diseases > Infectious diseases: Viral > Measles.
· Human Diseases > Infectious diseases: Viral > Influenza A.
· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.
· Human Diseases > Infectious diseases: Viral > HTLV-I infection.
· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.
· Human Diseases > Infectious diseases: Viral > Epstein-Barr virus infection.
· Human Diseases > Cancers: Overview > Pathways in cancer. (View pathway)
· Human Diseases > Cancers: Overview > Viral carcinogenesis.
· Human Diseases > Cancers: Specific types > Pancreatic cancer. (View pathway)
· Organismal Systems > Development > Osteoclast differentiation. (View pathway)
· Organismal Systems > Immune system > NOD-like receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > Th1 and Th2 cell differentiation. (View pathway)
· Organismal Systems > Immune system > Th17 cell differentiation. (View pathway)
文献引用
Application: WB Species: Mouse Sample: RAW 264.7 cells
Application: WB Species: Mice Sample:
Application: WB Species: Mouse Sample: bone marrow-derived mesenchymal stem cells (BMSCs)
限制条款
产品的规格、报价、验证数据请以官网为准，官网链接：www.affbiotech.com | www.affbiotech.cn（简体中文）| www.affbiotech.jp（日本語）产品的数据信息为Affinity所有，未经授权不得收集Affinity官网数据或资料用于商业用途，对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整，如您已订购该产品，请以订购时随货说明书为准，否则请以官网内容为准，官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时，请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.